Concerns raised about expansion of CAR T-cell therapy to common cancers

The potential expansion of CAR T-cell therapy to more common cancers will lead to a ramping up of patient need that Australia is currently not prepared for, an expert has warned. Speaking during the HSANZ symposium on T-cell therapeutics, Professor Michael Dickinson from the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital said that ...

Already a member?

Login to keep reading.

© 2022 the limbic